Recursion Pharmaceuticals Cash Flow Statement (2020-2025) | RXRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -18.34M-18.22M-22.47M-25.58M-30.48M-40.93M-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-65.33M-76.73M-93.02M-93.00M-91.37M-97.54M-95.84M-178.91M-202.49M-171.90M-162.25M
Depreciation and Depletion 1.00M1.00M1.10M1.10M1.40M2.40M2.50M2.50M2.70M2.70M2.90M3.10M3.60M4.00M4.20M4.20M4.00M4.10M4.00M6.20M
Share-based Compensation 1.26M0.77M1.07M1.19M1.82M5.32M3.36M4.34M5.63M5.67M8.91M7.70M8.81M11.81M16.79M16.09M16.13M16.52M18.25M30.78M36.06M26.16M25.24M
Gains from Investment Securities -0.02M0.17M-0.45M-0.47M-0.10M-2.38M-0.46M-1.16M1.55M2.44M-0.04M-4.78M3.52M-4.26M1.85M-4.50M0.56M5.94M-5.85M-8.23M-4.41M-4.69M2.44M
Asset Writedowns and Impairment 2.81M1.17M0.02M0.11M5.96M
Cash from Operations -17.82M-16.70M-19.46M8.57M-30.75M-33.65M-33.05M-61.16M77.39M-61.62M-54.54M-44.75M-73.32M-67.47M-72.92M-74.08M-102.30M-82.22M-59.23M-115.43M-131.96M-76.42M-117.36M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.94M1.02M0.86M1.12M1.40M2.33M2.44M2.24M2.77M2.79M2.99M3.21M3.73M5.54M7.58M7.55M7.38M8.97M7.20M12.95M19.33M23.85M21.04M
Change in Working Capital
Change in Receivables -0.08M-0.06M30.19M-30.04M-0.09M-0.01M-0.02M
Change in Account Payables 0.62M-0.53M-0.06M-0.22M2.05M0.07M3.13M-3.51M1.34M-0.99M0.71M0.69M-0.34M-2.52M2.19M-0.32M1.17M-1.34M-1.51M8.12M3.69M-4.84M-5.89M
Change in Accured Expenses -1.79M1.98M0.81M3.13M-0.14M1.13M10.13M1.64M-15.90M1.07M2.09M12.16M-9.85M6.20M7.58M2.78M-18.86M7.51M6.35M10.52M-26.59M11.38M-8.03M
Other Working Capital Changes 0.13M0.72M28.32M-2.50M2.83M-7.83M-2.50M-2.50M144.70M-7.65M-13.05M-13.68M-12.13M-11.07M-10.16M-7.72M-13.65M-12.64M3.92M-5.66M-27.13M-3.12M-3.53M
Investing Activities
Capital Expenditures 0.68M0.63M0.83M3.69M19.42M6.21M9.71M4.46M4.34M16.48M8.26M7.98M5.17M3.97M0.74M2.07M6.65M1.18M4.56M1.30M1.83M3.15M0.24M
Change in Intangibles 0.30M0.17M0.08M0.35M3.00M0.35M
Acquisitions 0.07M-277.10M
Divestments -4.44M
Change in Acquisitions & Divestments 69.19M147.65M21.41M61.55M0.48M
Cash from Investing Activities -0.68M-0.04M-3.43M-4.59M-19.42M-6.21M-193.87M-52.24M143.30M4.94M52.98M-7.98M-5.34M-2.05M-0.35M-2.49M-6.65M-4.18M-4.56M275.46M-7.27M-5.81M-2.55M
Financing Activities
Cash from Financing Activities 6.00M0.38M229.72M10.04M2.13M463.70M-11.10M3.80M2.08M2.67M2.34M147.26M1.92M3.79M53.77M80.66M13.90M263.12M16.46M10.64M40.53M97.66M251.34M
Additional items
Exchange Rate Effect -0.31M-0.00M0.18M-0.12M0.12M-0.22M-0.12M0.40M-3.47M4.83M9.26M1.87M
Change in Cash -12.50M-16.36M206.84M14.02M-48.04M423.84M-238.02M-109.61M222.78M-54.02M0.78M94.22M-76.73M-65.55M-19.62M4.22M-95.28M176.60M-46.92M167.19M-93.87M24.69M133.30M
Beginning Cash Balance 12.50M16.36M-206.84M248.11M262.12M208.90M632.74M394.72M285.12M507.89M453.87M455.69M549.88M471.42M406.94M387.35M391.60M297.74M474.57M427.16M594.32M500.42M526.54M
Free Cash Flow -18.50M-17.33M-20.28M4.89M-50.17M-39.87M-42.75M-65.62M73.05M-78.10M-62.80M-52.73M-78.49M-71.44M-73.67M-76.14M-108.95M-83.40M-63.79M-116.73M-133.79M-79.57M-117.60M
Net Cash Flow -12.50M-16.36M206.84M14.02M-48.04M423.84M-238.02M-109.61M222.78M-54.02M0.78M94.53M-76.73M-65.73M-19.50M4.09M-95.06M176.72M-47.33M170.66M-98.70M15.43M131.43M